See the DrugPatentWatch profile for wynzora
Is Wynzora Approved for Once-Daily Use?
Yes, Wynzora (calcipotriene and betamethasone dipropionate) cream is FDA-approved for once-daily application to treat plaque psoriasis in adults. Apply a thin layer to affected areas once per day for up to 4 weeks, then assess response.[1]
How Do You Apply Wynzora Correctly?
Clean and dry the skin, then rub in a pea-sized amount per 20 square inches of skin. Avoid face, groin, or armpits. Do not use occlusive dressings, as they increase absorption and side effect risks. Wash hands after application.[1][2]
What Happens If You Use It Twice Daily?
Twice-daily use is not recommended and exceeds the approved dosing. It raises risks of systemic absorption, including adrenal suppression from the corticosteroid component. Studies showed higher adverse events with more frequent application.[1]
Why Once Daily Instead of Twice?
The fixed-dose combination balances efficacy with safety. Clinical trials demonstrated similar plaque clearance to twice-daily calcipotriene/betamethasone ointment but with lower steroid exposure, reducing skin thinning and other steroid side effects.[1][3]
How Long Can You Safely Use Wynzora Daily?
Limit continuous use to 4 weeks due to corticosteroid risks like skin atrophy or HPA axis suppression. For flares, restart after a break. Long-term management may involve alternating with topical calcineurin inhibitors or phototherapy.[1][2]
Common Side Effects with Once-Daily Dosing
Most are mild and local: application-site irritation (7%), itching (3%), folliculitis (1%). Rare systemic effects include hypercalcemia from calcipotriene or Cushing's features from betamethasone. Discontinue if severe.[1]
[1]: Wynzora Prescribing Information (FDA)
[2]: Medscape - Wynzora Dosing
[3]: JAAD - Wynzora Phase 3 Trial